|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02552 HUA MEDICINE-B
Nominal 
2.575 -0.025 (-0.962%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (52,150) | (417,966) | 889,367 | (230,114) |
| Net Cash from / (used in) Investing Activities | -- | (654) | 10,043 | 8,077 | (4,752) |
| Net Cash from / (used in) Financing Activities | -- | 9,100 | 83,718 | 69,068 | 21,476 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (43,704) | (324,205) | 966,512 | (213,390) |
| Cash & Cash Equivalents at beginning of period | -- | 1,139,753 | 1,460,824 | 490,632 | 675,238 |
| Effect of Foreign Exchange Rate Changes | -- | (3,761) | 3,134 | 3,680 | 28,784 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,092,288 | 1,139,753 | 1,460,824 | 490,632 |
| Remarks: | Real time quote last updated: 24/08/2026 13:20 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -30,195 |
| %Change | -- |
| EPS / (LPS) | RMB -0.030 |
| NBV Per Share (¥) | RMB 0.940 |